Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey
Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Su Hyun Lee, Beomseok Suh, Hee-Young Shin, Hyun Joo Lee, Dae Ghon Kim, Jong Hyock Park
Cancer Res Treat. 2015;47(4):591-599. Published online 2015 Jan 5 DOI: https://doi.org/10.4143/crt.2014.086
Citations to this article as recorded by 
Choreographed expansion of services results in decreased patient burden without compromise of outcomes: An assessment of the Ontario experience
Kathryn Rzadki, Wafa Baqri, Olga Yermakhanova, Steven Habbous, Sunit Das
Neuro-Oncology Practice.2024; 11(2): 178. CrossRef
Primary Small Cell Carcinoma of the Kidney: Disease Characteristics and Treatment Outcomes
Thomas F. Monaghan, Kyle P. Michelson, Nicholas R. Suss, Christina W. Agudelo, Syed N. Rahman, Dennis J. Robins, Viktor X. Flores, Brian K. McNeil, Jeffrey P. Weiss, Andrew G. Winer
Medicines.2021; 8(1): 6. CrossRef
Rare cancers in India: A road less travelled
HS Darling, Sameer Rastogi
Indian Journal of Cancer.2020;[Epub] CrossRef
Cancer Patients’ Utilization of Tertiary Hospitals in Seoul Before and After the Benefit Expansion Policy
Sanghyun Cho, Youngs Chang, Yoon Kim
Journal of Preventive Medicine and Public Health.2019; 52(1): 41. CrossRef
Rare cancers—Rarity as a cost and value argument
J.-Matthias Graf von der Schulenburg, Frédéric Pauer
Journal of Cancer Policy.2017; 11: 54. CrossRef
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
Gemma Gatta, Riccardo Capocaccia, Laura Botta, Sandra Mallone, Roberta De Angelis, Eva Ardanaz, Harry Comber, Nadya Dimitrova, Maarit K Leinonen, Sabine Siesling, Jan M van der Zwan, Liesbet Van Eycken, Otto Visser, Maja P Žakelj, Lesley A Anderson, Franc
The Lancet Oncology.2017; 18(8): 1022. CrossRef